MD Anderson Receives $20M from Ross Perot for Work on Personalized Cancer Therapies | GenomeWeb

By Adam Bonislawski

The University of Texas MD Anderson Cancer Center announced last week that it has received $20 million from businessman Ross Perot to fund two initiatives – the Institute for Personalized Cancer Therapy and the Center for Targeted Therapy.

The donation will fund research at the centers exploring more effective drug treatments for cancer patients, including investigations into protein pathway-directed therapies, Stanley Hamilton, co-director of the IPCT, told ProteoMonitor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.